quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:08·500d
SECFiling
Longboard Pharmaceuticals Inc. logo

SEC Form EFFECT filed by Longboard Pharmaceuticals Inc.

LBPH· Longboard Pharmaceuticals Inc.
Health Care
Original source

Companies

  • LBPH
    Longboard Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Sep 10UpdateTruist$60.00
  • Jul 1UpdateCantor Fitzgerald$90.00
  • May 1UpdateRobert W. Baird$36.00
  • Feb 16UpdateCitigroup$40.00
  • Oct 24UpdateCantor Fitzgerald$35.00
  • Apr 27UpdateB. Riley Securities$13.00

Related

  • PR37d
    Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report
  • PR387d
    Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director
  • SEC497d
    SEC Form 15-12G filed by Longboard Pharmaceuticals Inc.
  • SEC499d
    SEC Form POSASR filed by Longboard Pharmaceuticals Inc.
  • SEC499d
    SEC Form RW WD filed by Longboard Pharmaceuticals Inc.
  • SEC500d
    SEC Form EFFECT filed by Longboard Pharmaceuticals Inc.
  • SEC500d
    SEC Form EFFECT filed by Longboard Pharmaceuticals Inc.
  • INSIDER507d
    SEC Form 4 filed by Director Lynch Casey
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022